- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostatic Hyperplasia, Benign in New Zealand
Total 1449 results
-
BayerCompleted
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); AbbVie; Rutgers Cancer Institute of New JerseyTerminated
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)Terminated
-
Advanced Accelerator ApplicationsCompletedProstate Cancer MetastaticUnited States
-
Bristol-Myers SquibbCompletedMetastatic Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCapcureCompletedCancer | ProstateUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Completed
-
Weill Medical College of Cornell UniversityCancer Research & Treatment Fund, IncTerminatedProstate CancerUnited States
-
Ashutosh Kumar TewariOncovir, Inc.Completed
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedProstate CancerUnited States
-
William K. OhProstate Cancer FoundationCompleted
-
NYU Langone HealthCompletedProstate CancerUnited States
-
Rockefeller UniversityMemorial Sloan Kettering Cancer CenterCompleted
-
Molecular Insight Pharmaceuticals, Inc.Completed
-
Molecular Insight Pharmaceuticals, Inc.Completed
-
AstraZenecaCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)Completed
-
Memorial Sloan Kettering Cancer CenterAmbrilia Biopharma, Inc.CompletedProstate CancerUnited States
-
Xanthus Pharmaceuticals, Inc.Completed
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States
-
James J. Peters Veterans Affairs Medical CenterNot yet recruitingMetastatic Cancer | Neoplasm, ProstateUnited States
-
Novartis PharmaceuticalsCompletedProstate CancerSaudi Arabia, Taiwan, Korea, Republic of, Lebanon, Brazil, China, New Zealand, Australia, Thailand, Kuwait
-
National Cancer Institute (NCI)CompletedProstate CancerUnited States
-
University of Alabama at BirminghamAmgenCompletedPhase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following TreatmentMetastatic Castration-resistant Prostate CancerUnited States
-
Novartis PharmaceuticalsTerminatedHormone Refractory Prostate Cancer DiseaseUnited States
-
Memorial Sloan Kettering Cancer CenterNo longer availableRecurrent Prostate Cancer | Prostate CancerUnited States
-
Columbia UniversityBristol-Myers Squibb; Ferring PharmaceuticalsActive, not recruiting
-
NYU Langone HealthTerminated
-
NYU Langone HealthCompleted
-
Weill Medical College of Cornell UniversityCompleted
-
Weill Medical College of Cornell UniversityCompleted
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Beth Israel Medical CenterBayerTerminatedProstate CancerUnited States
-
Columbia UniversityCelgene CorporationCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterWithdrawn
-
Memorial Sloan Kettering Cancer CenterCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Rockefeller UniversityCompletedSafety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells.Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterPSMA Development Corp, LLCCompleted
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerSpain, Taiwan, France, Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Sin... and more
-
University of RochesterWithdrawnProstate DiseaseUnited States
-
Weill Medical College of Cornell UniversityCompletedMetastatic Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
KangLaiTe USATerminated
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedProstate Cancer | Castration Resistant Prostate CancerUnited States
-
Johnson & Johnson Private LimitedWithdrawn
-
Roswell Park Cancer InstituteTerminated